FIELD: medicine.
SUBSTANCE: invention relates to a method for the prevention, relief or treatment of essential tremor, rest tremor, action tremor or their combined (complex) tremor in a subject, including the administration to a subject of therapeutically effective amount of a carbamate compound of the formula 2 or its pharmaceutically acceptable salt, solvate or hydrate, as well as to the use of a carbamate compound of the formula 2 or its pharmaceutically acceptable salt, solvate or hydrate for the prevention, relief or treatment of essential tremor, rest tremor, action tremor or their combined (complex) tremor.
EFFECT: effective treatment of essential tremor, rest tremor, action tremor or their combined (complex) tremor.
[Formula 2]
14 cl, 1 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PARKINSON'S DISEASE AND ESSENTIAL TREMOR | 2014 |
|
RU2558176C1 |
| CARBAMATE DERIVATIVES FOR USING IN PROPHYLAXIS OR TREATMENT IN MOTION DISORDER | 2002 |
|
RU2294739C2 |
| METHOD OF CORRECTING TREMOR IN EXPERIMENT | 2018 |
|
RU2678977C1 |
| NOVEL USING SUBSTITUTED AMINOMETHYLCHROMANS IN TREATMENT OF MOTION DISORDER OR UNDESIRABLE EFFECT CAUSED BY AGENTS THAT ARE ADMINISTRATED IN TREATMENT OF EXTRAPYRAMID MOTION DISORDER | 2002 |
|
RU2320336C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HEAD AND UPPER LIMBS TREMOR | 2016 |
|
RU2642984C1 |
| NOVEL USING 2-[5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL]-CHROMAN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS | 2002 |
|
RU2297833C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF FUNCTIONAL HAND TREMOR AND HAND TREMOR IN ORGANIC PATHOLOGY OF NERVOUS SYSTEM | 2024 |
|
RU2824927C1 |
| NEW USING (R)-(-)-2-[5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL]-CHROMAN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS | 2001 |
|
RU2278663C2 |
| NOVEL USE OF SUBSTITUTED AMINOMETHYLCHROMANS | 2002 |
|
RU2322443C2 |
| USE OF A CARBAMATE COMPOUND FOR THE REDUCTION OR TREATMENT OF DEVELOPMENTAL DISORDERS INCLUDING FRAGILE X SYNDROME, ANGELMANN SYNDROME, OR RETT SYNDROME | 2018 |
|
RU2793742C2 |
